Drug profile · INN
propranolol hydrochloride
HEMANGIOL
propranolol hydrochloride (HEMANGIOL) is a beta-2 adrenergic receptor antagonist. Associated with Eton Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
Drug details — propranolol hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 20
- Programs
- 1
- Data quality
- 0.89
Quick answer
propranolol hydrochloride (HEMANGIOL) is a beta-2 adrenergic receptor antagonist. Associated with Eton Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-2 adrenergic receptor antagonist
Primary target: Beta-1 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12186436
Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents
granted -
US 12083230
Nano-encapsulation using GRAS materials and applications thereof
granted -
US 11859234
Method of monitoring RNase L activity
granted -
US 11814625
Aptamers as a therapeutic tool to prevent protein aggregation in neurodegenerative disease
granted -
US 11737981
Cellulosic polymer nanoparticles and methods of forming them
granted -
US 11629174
Cryptic metabolites and method for activating silent biosynthetic gene clusters in actinomycete bacteria
granted -
US 11554101
Process for encapsulating soluble biologics, therapeutics, and imaging agents
granted -
US 11549950
Cryptic metabolites and method for activating silent biosynthetic gene clusters in diverse microorganisms
granted -
US 11486802
Methods and devices for high throughput purification
granted -
US 11376225
Composite flash-precipitated nanoparticles
granted -
US 11312756
Engineered potent cytotoxic stapled BH3 peptides
granted -
US 11147784
Dietary supplements and composition for treating cancer
granted -
US 11103461
Process for encapsulating soluble biologics, therapeutics, and imaging agents
granted -
US 11008551
Method to increase the infectivity of virus particles
granted -
US 10980990
Systems, devices, and/or methods for managing transdermal patches
granted -
US 10940119
Nano-encapsulation using GRAS materials and applications thereof
granted -
US 10905775
Particulate constructs for release of active agents
granted -
US 10883980
Methods and compositions for inhibiting hepatitis E virus
granted -
US 10852220
Methods and devices for high throughput purification
granted -
US 10842980
Systems, devices, and/or methods for managing transdermal patches
granted
Frequently asked questions
What is propranolol hydrochloride?
propranolol hydrochloride (HEMANGIOL) is a beta-2 adrenergic receptor antagonist. Associated with Eton Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for propranolol hydrochloride?
HEMANGIOL is a marketed brand name for propranolol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of propranolol hydrochloride?
propranolol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.